Business context and reporting period
This is Schweitzer-Mauduit International, Inc.’s Form 10-K for the fiscal year ended December 31, 2018, with unaudited quarterly results. The supplied filing does not identify Mativ Holdings, Inc. as the registrant. SWM operated two segments: Advanced Materials & Structures (AMS), which makes specialty resin-based materials, and Engineered Papers (EP), which primarily serves tobacco customers.
Financial performance and condition
| Metric | FY 2018 | FY 2017 |
|---|---|---|
| Net sales | $1,041.3 million | $982.1 million |
| Gross profit / margin | $278.5 million / 26.7% | $283.4 million / 28.9% |
| Operating profit / margin | $135.0 million / 13.0% | $128.3 million / 13.1% |
| Net income | $94.5 million | $34.5 million |
| Diluted EPS | $3.06 | $1.12 |
| Operating cash flow | $139.1 million | $131.0 million |
| Capital spending | $27.0 million | $37.2 million |
| Adjusted EBITDA | $196.9 million | $197.9 million |
Sales rose 6.0%, reflecting organic growth in both segments, Conwed contribution, and favorable currency. AMS sales increased 8.0% to $467.9 million; EP sales increased 4.5% to $573.4 million. Higher resin, pulp, and energy costs, plus AMS manufacturing inefficiencies and site-closure costs, reduced gross profit despite higher revenue. EP generated $121.8 million of operating profit versus AMS’s $49.5 million.
Net income improved substantially, but the comparison included significant nonrecurring and tax-related items: 2018 included a $15.0 million after-tax impairment of the CTS China joint-venture investment, a $7.7 million after-tax benefit from revaluing Conwed contingent consideration, and a favorable $13.0 million Tax Act adjustment. 2017 included $39.6 million of net Tax Act-related and other tax valuation allowance expenses. The 2018 effective tax rate was 9.2%, compared with 68.6% in 2017.
Cash and equivalents were $93.8 million at year-end, down from $106.9 million. Total debt was $622.1 million, versus $684.2 million; total debt-to-capital was 52.7%, versus 55.6%. Net operating working capital was $195.2 million. The company repaid $61.1 million net debt, paid $53.2 million in dividends, and reported $419.7 million of unused credit-facility capacity. Its $700 million credit agreement includes a $500 million revolver and $200 million term loan; it also issued $350 million of 6.875% senior notes due 2026. The company reported covenant compliance. The annual dividend was $1.73 per share.
For fourth-quarter 2018, sales were $248.7 million, gross profit $63.8 million, operating profit $26.8 million, and net income $7.2 million. In fourth-quarter 2017, the corresponding figures were $235.7 million, $67.1 million, $21.1 million, and a $27.3 million net loss.
Outlook, risks and notable items
Management expects long-term growth above broad economic benchmarks in selected AMS applications, including water filtration, surface-protection films, and infrastructure products; it generally expects AMS margin expansion with organic growth, excluding raw-material price effects. EP prospects remain exposed to declining cigarette consumption, currency movements, tobacco regulation, and adoption of reduced-risk products. No specific 2019 earnings or revenue guidance is provided. Planned 2019 capital spending is approximately $35–$40 million.
Key risks include tobacco-market decline and regulation; reliance on a small group of major tobacco customers; volatile resin, pulp, and energy costs and limited ability to pass through increases; foreign-exchange, interest-rate, trade, and geopolitical exposure; acquisition integration and restructuring execution; and competitive, capacity, and operational risks. Notable unresolved matters include Brazilian tax assessments, for which no liability was recorded, and a French labor judgment under appeal, also with no reserve recorded. SWM cited a $0.4 million reserve for a New Jersey landfill matter. The CTS impairment relied on Level 3 cash-flow estimates and could be subject to further valuation changes.
Most important facts for investors to verify
- Confirm the issuer and entity mapping: this filing is for Schweitzer-Mauduit International, Inc., not a registrant named Mativ Holdings, Inc.
- Separate recurring operating performance from the CTS impairment, contingent-consideration gain, and Tax Act benefits when assessing 2018 earnings.
- Track whether input-cost inflation, AMS site-transition costs, and lower gross margin persist or are offset by pricing, mix, and efficiency gains.
- Review debt service, covenant headroom, interest-rate exposure, and the sustainability of dividends against cash generation and investment needs.
- Monitor tobacco demand and customer concentration, CTS performance and valuation, and outcomes of the Brazilian tax and French labor proceedings.
- Compare actual 2019 capital spending and segment performance with management’s qualitative outlook and $35–$40 million capex estimate.